Inovio Biomedical Corp. (AMEX:INO)
| CAPS Rating |
|
|---|---|
| Open | $0.66 |
| Previous Close | $0.66 |
| Daily Range | $0.65 - $0.68 |
| 52-Week Range | $0.35 - $1.35 |
| Market Cap | $84.13M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 241,507 |
| Average Daily Volume | 0 |
INO
VS S&P 500 (SPY)
How do you think INO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
INO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
INO News and Commentary
- Health Care Conference Highlights Speculative Innovators – BloggingStocks
- Four Small Cap Healthcare Breakouts – SeekingAlpha
- INO – Blog at The Motley Fool
- Why We Love Wild Penny Stocks – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 7 Highly Rated Stocks on Sale – The Motley Fool
- Innovative Inovio – The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Is Avanir Pharmaceuticals the Perfect Stock? – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Curing Diseases Makes For a Bad Business Model – The Motley Fool
RSS Headlines
Fool UK
